Stock comparison
Enovis
ENOV$1.36BHealthcare Market cap, Sector
Jeena Sikho Lifecare Limited
JSLL.BO$70.06BHealthcare Market cap, Sector
Overall winner
Jeena Sikho Lifecare Limited
ENOV 07 JSLL.BO
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
ENOV0wins
7winsJSLL.BO
20F
B84
24F
A87
34F
A92
30F
C66
0F
B75
29F
A91
24F
A95
Side-by-side metrics
| Metric | ENOV | JSLL.BO |
|---|---|---|
| Market cap | $1.36B | $70.06B Winner |
| P/E (TTM) | Winner: - | 33.2x |
| EV/EBIT | Winner: - | 24.1x |
| ROIC (TTM) | 1.87% | 39.15% Winner |
| Gross margin | 56.81% | 88.58% Winner |
| Net margin | -49.91% | 27.68% Winner |
| Revenue CAGR 5y | 12.05% | 57.81% Winner |
| EPS CAGR 5y | - | 86.67% |
| Debt / Equity | 1.0x | 0.3x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ENOV leads on
- EV/EBIT-vs 24.1x+116%
- P/E (TTM)-vs 33.2x+104%
JSLL.BO leads on
- Net margin27.68%vs -49.91%+155%
- Market cap$70.06Bvs $1.36B+98%
- ROIC (TTM)39.15%vs 1.87%+95%
- Revenue CAGR 5y57.81%vs 12.05%+79%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.